Please assess the completion status of the following clinical trial:

Trial Title: Peanut Protein Supplementation to Prevent Muscle Atrophy and Improve Recovery Following Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* total knee arthroplasty scheduled within two weeks under the care of surgeons at the Jack Hughston Clinic~Exclusion Criteria:~* history of invasive lower extremity surgery within the last 5 years~* allergy to peanuts or peanut products~* Body Mass Index \<20 or \>35 kg/m2~* currently adhering to a restrictive weight loss diet~* current or recent (within the last 2 months) steroid use~* any physical condition that interferes with performing post-surgery rehabilitation~* known peripheral vascular disease, kidney disease, liver disease, or uncontrolled endocrine disorder~* known overt cardiovascular or metabolic such as heart disease/failure or diabetes~* Radiation exposure within the last 6 months other than dental x-rays or associated with current knee treatment/diagnosis

- Gender: ALL
- Minimum Age: 60 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Immediate Intervention Group (Type: EXPERIMENTAL): Participants will complete baseline measures and begin daily supplementation of peanut protein powder (72g/day) 7 days prior to total knee arthroplasty until 6 weeks after surgery.
- Wait-llist Control Group (Type: ACTIVE_COMPARATOR): Participants will complete baseline measures 7 days prior to total knee arthroplasty and will receive a 7 week supply after completion of 12 week post-surgery visit.

Based on this trial design, predict the completion outcome and termination type (if applicable).